Drug Shortage Report for IRBESARTAN

Last updated on 2020-03-25 History
Report ID 108484
Drug Identification Number 02385309
Brand name IRBESARTAN
Common or Proper name IRBESARTAN
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-03-27
Actual start date 2020-03-23
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-03-25
Company comments
Health Canada comments
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-25 French Compare
v3 2020-03-25 English Compare
v2 2020-03-11 French Compare
v1 2020-03-11 English Compare